PDX models Market 2027 By : Type, Tumor Type, Application, End Users, Impact of covid-19 pandemic. | The Insight Partners

PDX models Market Forecast to 2027 - COVID-19 Impact and Global Analysis By : Type (Mice Models, Rat Models); Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Hematological Tumor Models, Other Tumor Models); Application (Preclinical Drug Development, Basic Cancer Research, Biomarker Analysis); End Users (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutions), Impact of covid-19 pandemic.

Report Code: TIPRE00014250 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Patient derived xenografts (PDX) are oncology models in which the tissue or cells from a tumor of cancer patients are implanted into an immunodeficient or humanized mouse. PDX models have been used to develop an environment that promotes the natural growth of cancer, its monitoring, and accordingly evaluate the course of treatment for the original cancer patient. Various cancer drugs and therapies can be tested on xenografts to examine their efficacy before administering it to the patient's body. Patient-derived xenografts can be used to help with treatment planning and to understand the best treatment that can be given to the patient. They are also being used to develop new cancer drugs.

MARKET DYNAMICS

The PDX models market is driving due to the increasing demand for personalized medicine, increasing emphasis on cancer research from the government as well as private organizations, and growth in the number of R&D activities in the pharmaceutical industry. However, the high cost of personalized PDX models and stringent regulatory guidelines regarding the ethical use of animals in cancer research are expected to restrain the growth of this market during the forecast period.

MARKET SCOPE

The PDX Models market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of PDX Models market with detailed market segmentation by products and applications. The PDX Models market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in PDX Models market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The PDX Models market is segmented on the basis of type, tumor type, applications and end user. Based on type, the market is segmented as mice models, rat models. On the basis of tumor type market can be segmented as gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, other tumor models. On the basis of applications market can be segmented as preclinical drug development, basic cancer research, biomarker analysis. On the basis of end users market can be segmented as pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PDX Models market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PDX Models market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting PDX Models market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PDX Models market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the PDX Models market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PDX Models market are anticipated to have lucrative growth opportunities in the future with the rising demand for PDX Models in the global market. Below mentioned is the list of few companies engaged in the PDX Models market.

The report also includes the profiles of key players in PDX Models market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Crown Bioscience Inc.
  •  WuXi AppTec
  •  Champions Oncology, Inc..
  •  The Jackson Laboratory
  •  ONCODESIGN
  •  Charles River Laboratories International, Inc.
  •  EPO Berlin-Buch GmBH
  •  Shanghai LIDE Biotech Co., Ltd.
  •  Xentech
  •  Horizon Discovery Group PLC

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 PDX Models Market - By Type
1.3.2 PDX Models Market - By Tumor Type
1.3.3 PDX Models Market - By Application
1.3.4 PDX Models Market - By End Users
1.3.5 PDX Models Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PDX MODELS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PDX MODELS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PDX MODELS MARKET - GLOBAL MARKET ANALYSIS
6.1. PDX MODELS - GLOBAL MARKET OVERVIEW
6.2. PDX MODELS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PDX MODELS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MICE MODELS
7.3.1. Overview
7.3.2. Mice Models Market Forecast and Analysis
7.4. RAT MODELS
7.4.1. Overview
7.4.2. Rat Models Market Forecast and Analysis
8. PDX MODELS MARKET - REVENUE AND FORECASTS TO 2027 - TUMOR TYPE
8.1. OVERVIEW
8.2. TUMOR TYPE MARKET FORECASTS AND ANALYSIS
8.3. GASTROINTESTINAL TUMOR MODELS
8.3.1. Overview
8.3.2. Gastrointestinal Tumor Models Market Forecast and Analysis
8.4. GYNECOLOGICAL TUMOR MODELS
8.4.1. Overview
8.4.2. Gynecological Tumor Models Market Forecast and Analysis
8.5. RESPIRATORY TUMOR MODELS
8.5.1. Overview
8.5.2. Respiratory Tumor Models Market Forecast and Analysis
8.6. UROLOGICAL TUMOR MODELS
8.6.1. Overview
8.6.2. Urological Tumor Models Market Forecast and Analysis
8.7. HEMATOLOGICAL TUMOR MODELS
8.7.1. Overview
8.7.2. Hematological Tumor Models Market Forecast and Analysis
8.8. OTHER TUMOR MODELS
8.8.1. Overview
8.8.2. Other Tumor Models Market Forecast and Analysis
9. PDX MODELS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. PRECLINICAL DRUG DEVELOPMENT
9.3.1. Overview
9.3.2. Preclinical Drug Development Market Forecast and Analysis
9.4. BASIC CANCER RESEARCH
9.4.1. Overview
9.4.2. Basic Cancer Research Market Forecast and Analysis
9.5. BIOMARKER ANALYSIS
9.5.1. Overview
9.5.2. Biomarker Analysis Market Forecast and Analysis
10. PDX MODELS MARKET - REVENUE AND FORECASTS TO 2027 - END USERS
10.1. OVERVIEW
10.2. END USERS MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
10.4. CONTRACT RESEARCH ORGANIZATIONS
10.4.1. Overview
10.4.2. Contract Research Organizations Market Forecast and Analysis
10.5. ACADEMIC AND RESEARCH INSTITUTIONS
10.5.1. Overview
10.5.2. Academic and Research Institutions Market Forecast and Analysis
11. PDX MODELS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America PDX Models Market Overview
11.1.2 North America PDX Models Market Forecasts and Analysis
11.1.3 North America PDX Models Market Forecasts and Analysis - By Type
11.1.4 North America PDX Models Market Forecasts and Analysis - By Tumor Type
11.1.5 North America PDX Models Market Forecasts and Analysis - By Application
11.1.6 North America PDX Models Market Forecasts and Analysis - By End Users
11.1.7 North America PDX Models Market Forecasts and Analysis - By Countries
11.1.7.1 United States PDX Models Market
11.1.7.1.1 United States PDX Models Market by Type
11.1.7.1.2 United States PDX Models Market by Tumor Type
11.1.7.1.3 United States PDX Models Market by Application
11.1.7.1.4 United States PDX Models Market by End Users
11.1.7.2 Canada PDX Models Market
11.1.7.2.1 Canada PDX Models Market by Type
11.1.7.2.2 Canada PDX Models Market by Tumor Type
11.1.7.2.3 Canada PDX Models Market by Application
11.1.7.2.4 Canada PDX Models Market by End Users
11.1.7.3 Mexico PDX Models Market
11.1.7.3.1 Mexico PDX Models Market by Type
11.1.7.3.2 Mexico PDX Models Market by Tumor Type
11.1.7.3.3 Mexico PDX Models Market by Application
11.1.7.3.4 Mexico PDX Models Market by End Users
11.2. EUROPE
11.2.1 Europe PDX Models Market Overview
11.2.2 Europe PDX Models Market Forecasts and Analysis
11.2.3 Europe PDX Models Market Forecasts and Analysis - By Type
11.2.4 Europe PDX Models Market Forecasts and Analysis - By Tumor Type
11.2.5 Europe PDX Models Market Forecasts and Analysis - By Application
11.2.6 Europe PDX Models Market Forecasts and Analysis - By End Users
11.2.7 Europe PDX Models Market Forecasts and Analysis - By Countries
11.2.7.1 Germany PDX Models Market
11.2.7.1.1 Germany PDX Models Market by Type
11.2.7.1.2 Germany PDX Models Market by Tumor Type
11.2.7.1.3 Germany PDX Models Market by Application
11.2.7.1.4 Germany PDX Models Market by End Users
11.2.7.2 France PDX Models Market
11.2.7.2.1 France PDX Models Market by Type
11.2.7.2.2 France PDX Models Market by Tumor Type
11.2.7.2.3 France PDX Models Market by Application
11.2.7.2.4 France PDX Models Market by End Users
11.2.7.3 Italy PDX Models Market
11.2.7.3.1 Italy PDX Models Market by Type
11.2.7.3.2 Italy PDX Models Market by Tumor Type
11.2.7.3.3 Italy PDX Models Market by Application
11.2.7.3.4 Italy PDX Models Market by End Users
11.2.7.4 Spain PDX Models Market
11.2.7.4.1 Spain PDX Models Market by Type
11.2.7.4.2 Spain PDX Models Market by Tumor Type
11.2.7.4.3 Spain PDX Models Market by Application
11.2.7.4.4 Spain PDX Models Market by End Users
11.2.7.5 United Kingdom PDX Models Market
11.2.7.5.1 United Kingdom PDX Models Market by Type
11.2.7.5.2 United Kingdom PDX Models Market by Tumor Type
11.2.7.5.3 United Kingdom PDX Models Market by Application
11.2.7.5.4 United Kingdom PDX Models Market by End Users
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific PDX Models Market Overview
11.3.2 Asia-Pacific PDX Models Market Forecasts and Analysis
11.3.3 Asia-Pacific PDX Models Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific PDX Models Market Forecasts and Analysis - By Tumor Type
11.3.5 Asia-Pacific PDX Models Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific PDX Models Market Forecasts and Analysis - By End Users
11.3.7 Asia-Pacific PDX Models Market Forecasts and Analysis - By Countries
11.3.7.1 Australia PDX Models Market
11.3.7.1.1 Australia PDX Models Market by Type
11.3.7.1.2 Australia PDX Models Market by Tumor Type
11.3.7.1.3 Australia PDX Models Market by Application
11.3.7.1.4 Australia PDX Models Market by End Users
11.3.7.2 China PDX Models Market
11.3.7.2.1 China PDX Models Market by Type
11.3.7.2.2 China PDX Models Market by Tumor Type
11.3.7.2.3 China PDX Models Market by Application
11.3.7.2.4 China PDX Models Market by End Users
11.3.7.3 India PDX Models Market
11.3.7.3.1 India PDX Models Market by Type
11.3.7.3.2 India PDX Models Market by Tumor Type
11.3.7.3.3 India PDX Models Market by Application
11.3.7.3.4 India PDX Models Market by End Users
11.3.7.4 Japan PDX Models Market
11.3.7.4.1 Japan PDX Models Market by Type
11.3.7.4.2 Japan PDX Models Market by Tumor Type
11.3.7.4.3 Japan PDX Models Market by Application
11.3.7.4.4 Japan PDX Models Market by End Users
11.3.7.5 South Korea PDX Models Market
11.3.7.5.1 South Korea PDX Models Market by Type
11.3.7.5.2 South Korea PDX Models Market by Tumor Type
11.3.7.5.3 South Korea PDX Models Market by Application
11.3.7.5.4 South Korea PDX Models Market by End Users
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa PDX Models Market Overview
11.4.2 Middle East and Africa PDX Models Market Forecasts and Analysis
11.4.3 Middle East and Africa PDX Models Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa PDX Models Market Forecasts and Analysis - By Tumor Type
11.4.5 Middle East and Africa PDX Models Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa PDX Models Market Forecasts and Analysis - By End Users
11.4.7 Middle East and Africa PDX Models Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa PDX Models Market
11.4.7.1.1 South Africa PDX Models Market by Type
11.4.7.1.2 South Africa PDX Models Market by Tumor Type
11.4.7.1.3 South Africa PDX Models Market by Application
11.4.7.1.4 South Africa PDX Models Market by End Users
11.4.7.2 Saudi Arabia PDX Models Market
11.4.7.2.1 Saudi Arabia PDX Models Market by Type
11.4.7.2.2 Saudi Arabia PDX Models Market by Tumor Type
11.4.7.2.3 Saudi Arabia PDX Models Market by Application
11.4.7.2.4 Saudi Arabia PDX Models Market by End Users
11.4.7.3 U.A.E PDX Models Market
11.4.7.3.1 U.A.E PDX Models Market by Type
11.4.7.3.2 U.A.E PDX Models Market by Tumor Type
11.4.7.3.3 U.A.E PDX Models Market by Application
11.4.7.3.4 U.A.E PDX Models Market by End Users
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America PDX Models Market Overview
11.5.2 South and Central America PDX Models Market Forecasts and Analysis
11.5.3 South and Central America PDX Models Market Forecasts and Analysis - By Type
11.5.4 South and Central America PDX Models Market Forecasts and Analysis - By Tumor Type
11.5.5 South and Central America PDX Models Market Forecasts and Analysis - By Application
11.5.6 South and Central America PDX Models Market Forecasts and Analysis - By End Users
11.5.7 South and Central America PDX Models Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil PDX Models Market
11.5.7.1.1 Brazil PDX Models Market by Type
11.5.7.1.2 Brazil PDX Models Market by Tumor Type
11.5.7.1.3 Brazil PDX Models Market by Application
11.5.7.1.4 Brazil PDX Models Market by End Users
11.5.7.2 Argentina PDX Models Market
11.5.7.2.1 Argentina PDX Models Market by Type
11.5.7.2.2 Argentina PDX Models Market by Tumor Type
11.5.7.2.3 Argentina PDX Models Market by Application
11.5.7.2.4 Argentina PDX Models Market by End Users
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PDX MODELS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest of the World
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. PDX MODELS MARKET, KEY COMPANY PROFILES
14.1. CROWN BIOSCIENCE INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. WUXI APPTEC
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. CHAMPIONS ONCOLOGY, INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. THE JACKSON LABORATORY
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ONCODESIGN
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. EPO BERLIN-BUCH GMBH
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. SHANGHAI LIDE BIOTECH CO., LTD.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. XENTECH
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. HORIZON DISCOVERY GROUP PLC
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Crown Bioscience Inc.
2. WuXi AppTec
3. Champions Oncology, Inc..
4. The Jackson Laboratory
5. ONCODESIGN
6. Charles River Laboratories International, Inc.
7. EPO Berlin-Buch GmBH
8. Shanghai LIDE Biotech Co., Ltd.
9. Xentech
10. Horizon Discovery Group PLC
TIPRE00014250
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking